Matrix Metalloproteinase 1 (MMP1) Is Associated with Early-Onset Lung Cancer

@article{Sauter2008MatrixM1,
  title={Matrix Metalloproteinase 1 (MMP1) Is Associated with Early-Onset Lung Cancer},
  author={Wiebke Sauter and Albert Rosenberger and Lars Beckmann and Silke Kropp and Kirstin Mittelstrass and Maria N Timofeeva and Gabi W{\"o}lke and A Steinwachs and Daniela Scheiner and Eckart U. Meese and Gerhard W. Sybrecht and Florian Kronenberg and Hendrik C Dienemann and Jenny Chang-Claude and Thomas Illig and Heinz-Erich Wichmann and Heike Bickeb{\"o}ller and Angela Risch},
  journal={Cancer Epidemiology Biomarkers \& Prevention},
  year={2008},
  volume={17},
  pages={1127 - 1135}
}
Matrix metalloproteinases (MMP) play a key role in the breakdown of extracellular matrix and in inflammatory processes. MMP1 is the most highly expressed interstitial collagenase degrading fibrillar collagens. Overexpression of MMP1 has been shown in tumor tissues and has been suggested to be associated with tumor invasion and metastasis. Nine haplotype tagging and additional two intronic single nucleotide polymorphisms (SNP) of MMP1 were genotyped in a case control sample, consisting of 635… 

Figures and Tables from this paper

Identification of genes associated with matrix metalloproteinases in invasive lung adenocarcinoma
TLDR
To identify genes with similar function to that of matrix metalloproteinases (MMPs) in invasive lung adenocarcinoma (AC) and to screen the transcription factors that regulate MMPs, the gene expression dataset GSE2514 was downloaded from the Gene Expression Omnibus database.
A functional polymorphism (−1607 1G→2G) in the matrix metalloproteinase‐1 promoter is associated with development and progression of lung cancer
TLDR
The authors hypothesized that this MMP‐1 polymorphism may affect susceptibility to the development and progression of cancer.
Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.
  • R. Roy, Jiang Yang, M. Moses
  • Biology
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2009
The matrix metalloproteinase (MMP) family of enzymes is comprised of critically important extracellular matrix remodeling proteases whose activity has been implicated in a number of key normal and
Matrix Metalloproteinase Mmp-1a Is Dispensable for Normal Growth and Fertility in Mice and Promotes Lung Cancer Progression by Modulating Inflammatory Responses*
TLDR
It is proposed that Mmp1a knock-out mice provide an excellent in vivo model for the functional analysis of human MMP-1 in both physiological and pathological conditions and could play a role in tumor progression by modulating the polarization of a Th1/Th2 inflammatory response to chemical carcinogens.
Single nucleotide polymorphisms in matrix metalloproteinase genes and lung cancer chemotherapy response and prognosis
TLDR
This study identified SNPs in MMP1, MMP2, M MP7 and MMP12 for further investigation as possible predictors of chemotherapy outcome in lung cancer patients.
Expression of metastasis-associated molecules in non-small cell lung cancer and their prognostic significance.
TLDR
The results suggest that MMP-1 and COX-2 are plausible candidate survival markers for NSCLC, and the expression scores of each marker were correlated with TNM stage and patient survival data.
Null Results in Brief No Association between Matrix Metalloproteinase (MMP)-1, MMP-3, and MMP-7 SNPs and Endometrial Cancer Risk
TLDR
This comprehensive study of individual genetic variation across M MP-1, MMP-3, and MMP -7 was undertaken to evaluate associations with endometrial cancer susceptibility.
Investigation of MMP-1 genetic polymorphisms and protein expression and their effects on the risk of Kashin-Beck disease in the northwest Chinese Han population
TLDR
The increased expression of MMP-1 has a potential effect on the risk of KBD in the northwest Chinese Han population, however, six selected SNPs in the M MP-1 gene might not be useful as significant markers for predicting KBD susceptibility in ChineseHan population.
Matrix Metalloproteinase 1: Role in Sarcoma Biology
TLDR
Findings indicating tumor cell production of MMP1 by sarcoma cells is novel and highlights the fundamental differences in MMP biology between carcinomas and sarcomas.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 66 REFERENCES
A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility.
TLDR
It is demonstrated that the 2G/2G genotype enhances lung cancer susceptibility especially in current smokers and is the first molecular epidemiological evidence of the MMP-1 promoter polymorphism associated with the development of lung cancer in the presence of continuing carcinogenic exposure.
Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness.
  • G. Ghilardi, M. Biondi, R. Scorza
  • Biology, Medicine
    Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2001
TLDR
The results suggest that the presence of 2G polymorphism at the MMP-1 promoter region may favor the growth and the metastatic process in CRC patients and could be looked at as a risk factor for a worse prognosis.
Matrix Metalloproteinase-1 Promoter Polymorphism and Lung Cancer Risk
TLDR
Genotypes containing the 2G allele of the MMP-1 polymorphism are associated with higher risk of lung cancer in never-smokers and in males, in conclusion.
Haplotypes in Matrix Metalloproteinase Gene Cluster on Chromosome 11q22 Contribute to the Risk of Lung Cancer Development and Progression
TLDR
The observed multiple cancer-associated genetic variants suggested that the MMP1-MMP3-M MP12 gene cluster plays important roles in lung cancer development and progression.
Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression
TLDR
Although the study suggests some correlations between the studied SNPs and the progression of breast cancer, the rarity of the risk genotypes limits their usefulness in the clinic.
An association between the matrix metalloproteinase 1 promoter gene polymorphism and lymphnode metastasis in breast cancer.
TLDR
The results suggest that allele 2G may be associated with lymphnode metastasis in patients with breast cancer and therefore it can be considered as a prognostic marker in this disease.
Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China.
TLDR
The present result suggested that the M MP3 promoter polymorphism may modify susceptibility to NSCLC, and the MMP 1G/5A haplotype may predicate the risk of lymphatic metastasis of this tumor.
Matrix metalloproteinase–1 is associated with poor prognosis in colorectal cancer
TLDR
It is found that the presence of MMP–1 in colorectal cancer is associated with a poor prognosis and has prognostic value independent of Dukes stage, and treatment of those individuals whose colon tumors produce M MP–1 with MMP inhibitors is a therapeutic strategy worth pursuing.
Interstitial collagenases as markers of tumor progression.
TLDR
Evidence indicates that elevated expression of the interstitial collagenases is associated with a poor prognosis in a variety of cancers, and therefore, these MMPs can serve as a marker of tumor progression.
Haplotype Effects on Matrix Metalloproteinase-1 Gene Promoter Activity in Cancer Cells
TLDR
The results suggest that the polymorphisms exert haplotype effects on the transcriptional regulation of the MMP1 gene in cancer cells, and indicate a need to examine haplotypes rather than any single polymorphism in genetic epidemiologic studies of theMMP1 genes in cancers.
...
1
2
3
4
5
...